WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

Raccontata damorningstar.comynetnews.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
morningstar.comStai leggendo1 g fa

Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

originale
ynetnews.com1 g fa

Japanese medtech giant buys Israeli maker of prostate cancer protection device in $270M deal

Olympus will buy the Netanya-based maker of a biodegradable balloon implant that protects healthy tissue during prostate cancer radiation therapy, with operations expected to remain in Israel

Leggi questa versione → originale

Timeline cronologica

  1. martedì 26 maggio 2026·morningstar.com

    Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

    Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

  2. mercoledì 27 maggio 2026·ynetnews.com

    Japanese medtech giant buys Israeli maker of prostate cancer protection device in $270M deal

    Olympus will buy the Netanya-based maker of a biodegradable balloon implant that protects healthy tissue during prostate cancer radiation therapy, with operations expected to…